statistiche ricercatore

Continente	#
EU - Europa	297
NA - Nord America	295
AS - Asia	222
SA - Sud America	58
Continente sconosciuto - Info sul continente non disponibili	19
AF - Africa	13
Totale	904

Nazione	#
US - Stati Uniti d'America	278
RU - Federazione Russa	207
SG - Singapore	114
BR - Brasile	39
CN - Cina	38
IT - Italia	30
HK - Hong Kong	28
GB - Regno Unito	13
VN - Vietnam	13
DE - Germania	12
FR - Francia	11
AR - Argentina	7
IN - India	7
MX - Messico	7
FI - Finlandia	5
ZA - Sudafrica	5
BD - Bangladesh	4
CA - Canada	4
ID - Indonesia	4
CO - Colombia	3
PK - Pakistan	3
SE - Svezia	3
EG - Egitto	2
JP - Giappone	2
LT - Lituania	2
MA - Marocco	2
MY - Malesia	2
PL - Polonia	2
PT - Portogallo	2
PY - Paraguay	2
UY - Uruguay	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AT - Austria	1
BB - Barbados	1
BO - Bolivia	1
CL - Cile	1
DK - Danimarca	1
DZ - Algeria	1
EC - Ecuador	1
EE - Estonia	1
ES - Italia	1
ET - Etiopia	1
GD - Grenada	1
GE - Georgia	1
GT - Guatemala	1
HR - Croazia	1
HU - Ungheria	1
IE - Irlanda	1
JM - Giamaica	1
JO - Giordania	1
KW - Kuwait	1
LU - Lussemburgo	1
NG - Nigeria	1
NL - Olanda	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
SV - El Salvador	1
TN - Tunisia	1
TR - Turchia	1
TT - Trinidad e Tobago	1
UZ - Uzbekistan	1
Totale	885

Nome	#
68Ga-PSMA-11 PET/MRI versus multiparametric MRI in men referred for prostate biopsy: primary tumour localization and interreader agreement	135
Preliminary Findings of the Role of FAPi in Prostate Cancer Theranostics	125
Infiltrative growth pattern of prostate cancer is associated with lower uptake on PSMA PET and reduced diffusion restriction on mpMRI	93
Combined forced diuresis and late acquisition on [68Ga]Ga-PSMA-11 PET/CT for biochemical recurrent prostate cancer: a clinical practice-oriented study	92
Is There a Role of Interim PSMA PET in Chemotherapy of Prostate Cancer?	70
Correction: PSMA‑positive prostatic volume prediction with deep learning based on T2‑weighted MRI	69
PSMA-positive prostatic volume prediction with deep learning based on T2-weighted MRI	67
Can We Predict Skeletal Lesion on Bone Scan Based on Quantitative PSMA PET/CT Features?	64
Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patients	63
Immunohistochemical ERG positivity is associated with decreased PSMA expression and lower visibility in corresponding [68Ga] Ga‑PSMA‑11 PET scans of primary prostate cancer	58
Unspecic bone uptakes in PSMA PET for prostate cancer: why do they matter?	56
Is there a role for early SSTR-targeting PRRT in GEP-NET?	12
Totale	904

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	7	0	0	0	0	0	0	0	0	0	7	0	0
2023/2024	9	0	1	0	1	0	1	0	4	0	1	0	1
2024/2025	154	0	0	0	3	12	3	28	9	33	15	23	28
2025/2026	615	57	40	28	44	77	101	67	62	88	35	9	7
2026/2027	119	19	31	23	41	5	0	0	0	0	0	0	0
Totale													904